News

The lecturership recognizes Dr. Lyden's transformative contributions to cancer research.

Soon-to-graduate students of Weill Cornell Medicine-Qatar have gained residency places at prestigious health care institutions in Qatar and the United States, marking another successful Match Day for the college. 

Dr. Won Jun Kim, Tri-Institutional M.D.-Ph.D. student, was named a winner of the 2026 Harold M. Weintraub Graduate Student Award by the Fred Hutchinson Cancer Center. 

Family physicians who report feeling burned out are nearly 1.5 times more likely to change practices or stop...

Awards, honors and achievements for the month of March.

Six researchers from Weill Cornell Medicine have received Young Investigator Awards from the Prostate Cancer Foundation. 

NEW YORK (March 25, 2026)—Dr. Y. Michael Shim, an esteemed physician-scientist who specializes in advanced...

On March 20, the Class of 2026 learned where they will be doing their internship and residency training—setting the stage for the next several years of their medical careers and lives.

Applying artificial intelligence techniques to cardiac ultrasound data may make it easier to identify patients with advanced heart failure, a new study has found. 

More than 100 students from across Cornell campuses and 17 other universities gathered in New York City March 6–8 for the Cornell Health AI Hackathon.

As the conflict engulfing the Middle East complicates clinical instruction for medical students at Weill Cornell Medicine-Qatar, medical education leadership in New York has rapidly launched telehealth electives to help students in Doha complete their education.

An enigmatic type of circulating tumor cell called a dual-positive cell is associated with shorter survival time in patients with advanced breast cancer, according to a study led by investigators at Weill Cornell Medicine. 

Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study led by Weill Cornell Medicine investigators. 

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center. 

State laws that ban insurance prior authorization for buprenorphine—a leading medication for opioid use disorder—may not help more patients stay in treatment for the recommended minimum of 180 days, Weill Cornell Medicine researchers report. 

A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.

Dr. Ekta Khurana, an associate professor of systems and computational biomedicine at Weill Cornell Medicine, has received a two-year, $1 million Challenge Award from the Prostate Cancer Foundation to work with researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center on an AI-based method for early detection of treatment-resistant prostate tumor subtypes.

Fourteen members of Cornell’s faculty and staff are being recognized this year with Community-Engaged Practice and Innovation Awards from the David M. Einhorn Center for Community Engagement. 

Two Weill Cornell Medicine physician-scientists, Dr. Hooman Kamel and Dr. Robert Peck, have been elected members of the American Society for Clinical Investigation (ASCI) for 2026.  

Awards, honors and achievements for the month of February.